Antidepressive AgentsAntipsychotic AgentsDepressive Disorder, Major
Dr. Arifulla - Khan, MD
NPI1134241888
- Publications
- 8
- Clinical trials
- 27
- Industry payments
- $9,264
- Affiliated sites
- 1
- Medical group
- 1
- Practice address
- 1900 116th Ave Ne, Bellevue, WA 98004
- Practice phone
- Call (206) 486-6664
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Optimo Anesthesia
Pediatric practice · Bellevue, Washington
Find Dr. Khan's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Arifulla - Khan is a psychiatrist in Bellevue, Washington
Dr. Khan practices at Optimo Anesthesia in Bellevue, Washington.
Dr. Khan's NPI, 1134241888, was assigned on April 4, 2007. Dr. Khan holds Washington license 21545.
NPI and contact details
- NPI
- 1134241888NPI Registry (opens in a new tab)
- NPI enumeration date
- April 4, 2007
- NPI status
- Active
- Practice phone
- (206) 486-6664
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Arifulla - Khan practices at Optimo Anesthesia in Bellevue, Washington
Dr. Khan's primary practice is Optimo Anesthesia, at 1900 116th Ave Ne, Bellevue, WA 98004. The practice phone is (206) 486-6664.
- Optimo Anesthesia1900 116th Ave Ne, Bellevue, WA 98004Phone(206) 486-6664
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Arifulla - Khan is affiliated with 1 site of care and 1 medical group
Dr. Khan's primary practice is Optimo Anesthesia in Bellevue, Washington. Dmand AI also links Dr. Khan to 1 medical group, named with a free account.
Optimo AnesthesiaPrimary
Sources: Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dmand AI tracks the EHR system at Dr. Arifulla - Khan's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khan practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Optimo Anesthesia | Available with a free account |
| +1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every site where Dr. Khan practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Arifulla - Khan is one of 758 psychiatrists in Washington
Psychiatry is Dr. Khan's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Khan is licensed in Washington.
Specialties and state licenses
- Psychiatry, WashingtonPrimary
Psychiatrists near Dr. Khan
Counts of psychiatrists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Arifulla - Khan's patients have a median age of 72
Across all payers, Dmand AI patient panel data puts Dr. Khan's median patient age at 72, with 62% women.
Dr. Khan's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 72
Patient panel by sex, all payers
- Women62%
- Men38%
Source: Dmand AI Patient Panel Data
Dr. Arifulla - Khan has 8 publications on record
Dmand AI links 8 papers to Dr. Khan, published from 2020 to 2023. The most frequent topics are Double-Blind Method, Psychiatric Status Rating Scales and Antidepressive Agents. Dr. Khan's most frequent co-authors are Sarah Jane Atkinson, MD, Sanjeev Pathak, MD and Maurizio Fava, MD.
Papers8
Years published2020 to 2023
Topics Dr. Khan writes about most
- Double-Blind Method
- Psychiatric Status Rating Scales
- Antidepressive Agents
- Antipsychotic Agents
- Anxiety Disorders
- Delayed-Action Preparations
- Dibenzothiazepines
- Placebos
Dr. Khan's most frequent co-authors
- Sarah Jane Atkinson, MD3 shared papers
- Sanjeev Pathak, MD2 shared papers
- Maurizio Fava, MD1 shared paper
Recent publications by Dr. Khan
Semin Arthritis Rheum
AnalgesicsAntibodies, Monoclonal, HumanizedDouble-Blind Method
J Clin Psychopharmacol
Anxiety DisordersDelayed-Action PreparationsDibenzothiazepines
Antipsychotic AgentsAnxiety DisordersDelayed-Action Preparations
See who Dr. Khan researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Khan works with, so you can find a warm path to the right psychiatrists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Arifulla - Khan has worked on 27 clinical trials
Dmand AI links Dr. Khan to 27 clinical trials, 2 of them phase 2 studies. 7 are still active or recruiting. Conditions studied include Migraine Disorders, Headache and Headache Disorders, Primary. Eli Lilly and Company sponsors the most, 23. Open Payments lists research payments to Dr. Khan that name 22 trials.
Clinical trials with Dr. Khan by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 1Phase 3: 1 trial
- NonePhase 4: no trials
Conditions in Dr. Khan's trials
- Migraine Disorders
- Headache
- Headache Disorders, Primary
- Alzheimer Disease
- Cluster Headache
Investigators on the most trials with Dr. Khan
- Arkadiy Stolyar, MD12 shared trials
- David J. Dibenedetto, MD11 shared trials
- Peter J. McAllister, MD10 shared trials
Recent clinical trials with Dr. Khan
Depressive Disorder, Treatment-ResistantDepressive DisorderNV-5138
A Randomized, Placebo-Controlled, Double-Blind Study of ATH-1017 Treatment in Subjects With Mild to Moderate Alzheimer's Disease (opens in a new tab)
CompletedPhase 2/3
Alzheimer DiseaseTauopathiesATH-1017
Migraine DisordersHeadache Disorders, PrimaryABP-450
Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease (opens in a new tab)
TerminatedPhase 3
Alzheimer DiseaseTauopathiesSimufilam
$549 in research paymentsMigraine DisordersHeadache Disorders, PrimaryLasmiditan
Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Arifulla - Khan received $9,264 in industry payments from 2016 to 2022
CMS Open Payments shows 36 general payments to Dr. Khan from 6 drug and device companies from 2016 to 2022. Consulting fees make up the largest share, 36% of the total. Pfizer Inc. paid the most, $4,439. It also lists 131 research payments totaling $502,196 from 2016 to 2024, naming 22 clinical trials.
General payments to Dr. Khan by program year, 2016 to 2022
General payments to Dr. Khan by kind, 2016 to 2022
$9.3Kin total
- Consulting fees$3,32536%
- Food and beverage$2,71829%
- Travel and lodging$2,24124%
- Speaker and faculty fees$94010%
- Education$400%
Companies that paid Dr. Khan the most, 2016 to 2022
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Arifulla - Khan's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Arifulla - Khan
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Arifulla - Khan's NPI number?
Dr. Arifulla - Khan's NPI number is 1134241888. It was assigned on April 4, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Arifulla - Khan?
Dr. Arifulla - Khan is a psychiatrist in Bellevue, Washington. The primary specialty in the NPI Registry is Psychiatry Physician (taxonomy code 2084P0800X).
Where does Dr. Arifulla - Khan practice?
Dr. Khan practices at 1900 116th Ave Ne, Bellevue, WA 98004. Dr. Khan's primary practice is Optimo Anesthesia in Bellevue, Washington. Dmand AI also links Dr. Khan to 1 medical group.
What is Dr. Arifulla - Khan's office phone number?
The practice phone on file for Dr. Khan is (206) 486-6664.
What is Dr. Arifulla - Khan's medical license number?
Dr. Khan holds Washington license 21545.
Has Dr. Arifulla - Khan received payments from drug or device companies?
CMS Open Payments shows $9,264 in general payments to Dr. Khan from 6 companies from 2016 to 2022. The largest total came from Pfizer Inc.
How long has Dr. Arifulla - Khan been practicing?
Dr. Khan's NPI was assigned in 2007.
Does Dr. Arifulla - Khan do research?
Dmand AI links 8 publications to Dr. Khan, published from 2020 to 2023. Dr. Khan has worked on 27 clinical trials.
Who does Dr. Arifulla - Khan publish with?
Dr. Khan's most frequent co-authors are Sarah Jane Atkinson, MD (3 shared papers), Sanjeev Pathak, MD (2 shared papers) and Maurizio Fava, MD (1 shared paper).
Selling to psychiatry practices?
See psychiatrists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card